Department of Defense’s efforts to ensure servicemembers’ access to safe, high-quality pharmaceuticals, Hearing Before the Subcommittee on Personnel, Senate Armed Services Committee : Congressional Research Service (CRS) , April 30 , 2024
Department of Defense’s efforts to ensure servicemembers’ access to safe, high-quality pharmaceuticals, Hearing Before the Subcommittee on Personnel, Senate Armed Services Committee : Congressional Research Service (CRS) , April 30 , 2024
From the document: "Chair Warren, Ranking Member Scott, and distinguished members of the subcommittee, thank you for the opportunity to appear before you today to discuss the Department of Defense’s efforts to ensure servicemembers’ access to safe, high-quality pharmaceuticals. My name is Bryce Mendez, and I am a specialist in defense health care policy at the Congressional Research Service (CRS). CRS provides Congress with policy research and analysis that is authoritative, objective, and nonpartisan in accordance with our authorizing statute (2 U.S.C. §166).
As requested by the committee, my testimony today will provide an overview of Department of Defense (DOD) medical research and development (R&D) capabilities, discuss how and why DOD uses those capabilities to develop drugs and biologics, and how DOD aims to ensure that developed drugs and biologics are safe and effective for human use. 1 I will also discuss several considerations that Congress may face with regard to DOD medical R&D and manufacturing of drugs and biologics"
Authors - United States SenateSubjects
Authors
Publishers
Format
Related Resources
